MedTechIndexBETA
The MedTechIndex Briefing

Keep up with MedTechIndex.

A weekly note from Blair, new companies added to the directory, and meaningful updates to existing profiles.

Confirm your email to join. Email privacy

Companies / Neocis
Medical device company profile

Neocis

Yomi robotic planning and guidance systems for dental implant surgery.

Medical Device ManufacturerDental & Oral HealthImplant DentistryCommercial-stage
HeadquartersπŸ‡ΊπŸ‡ΈMiami, Florida, United States
Founded2009
Commercial statusCommercially availableSelected products commercially offered; availability and indications vary by product and market.
EmployeesNot confirmed
Estimated revenueNot confirmed
Disclosed fundingUS$20 million [36]Disclosed round Β· 2023
Official websitewww.neocis.com β†—

Company overview

Neocis develops Yomi, a robotic platform supporting dental implant planning and surgical guidance. The system combines preoperative software with haptic guidance of surgical instruments, keeping the clinician in control of the procedure.

The Miami-based company introduced its next-generation Yomi S system in November 2025 following an October 2025 FDA 510(k) clearance. The clearance is device-specific; future indications and features under development are separate from currently authorized workflows.

Co-founder Alon Mozes leads Neocis, with Brent Berthy serving as president. Commercial adoption depends on clinical training, integration into dental practice workflows and capital-equipment purchasing, alongside evidence supporting accuracy and procedural efficiency.

[31][33][34][35][36]

Leadership

4 people
Alon MozesCEO & Co-Founder [35]
Brent BerthyPresident [35]
Juan SalcedoEngineering Fellow & Co-Founder [35]
Dennis MosesChief Technical Officer [35]

Products & regulatory status How does MedTechIndex get this information?

Summary

Yomi S has its own 510(k) decision, K252376. Earlier Yomi/Neocis Guidance System decisions document the platform’s evolution, including planning software and splint configurations; they should not all be counted as clearances of the current Yomi S model. [33][31][19][35][1]

The matched FDA history contains 3 distinct recall events: 0 open, 3 terminated. Z-0929-2021 (2020-10-30; terminated): The LRUL and LLUR posterior chairside splints and the LLUR anterior chairside splints may be mislabeled. Z-2637-2020 (2020-05-14; terminated): The LRUL and LLUR posterior chairside splints and LLUR anterior chairside splints may be mislabeled. Z-0511-2020 (2019-10-04; terminated): The Fiducial Array may mismatch their measurement files resulting in failed landmark check. [27][24][25][26][23]

Regulatory snapshot How to read this snapshot

U.S. FDA
1
510(k) clearances
0
De Novo grants
0
PMA approvals
0
Recall events

Latest recorded source review: 2026-10-20.

Commercial portfolio snapshot

Documented commercial product families.

Dental surgical robot

Yomi S Robotic System β†—

Next-generation robotic planning and guidance platform for dental implantation. [33][30]

FDA-cleared

Commercially offered; exact model and country availability should be confirmed with the manufacturer.

Activity & Milestones

1 events
2025-11-17 Β· Commercialization

Yomi S introduced

Next-generation Yomi S robotic system introduced following 510(k) clearance. [31]

36 Cited Sources

Accessed 10/29/2026

[1] FDA 510(k) database β€” research search β†—FDA / openFDA Β· regulatory record
[2] FDA K161399 β€” Neocis Guidance System β†—U.S. Food and Drug Administration Β· regulatory record
[3] FDA K173402 β€” Neocis Guidance System (NGS) with Chairside Splint β†—U.S. Food and Drug Administration Β· regulatory record
[4] FDA K182776 β€” Neocis Guidance System β†—U.S. Food and Drug Administration Β· regulatory record
[6] FDA K191605 β€” Neocis Guidance System (NGS) β†—U.S. Food and Drug Administration Β· regulatory record
[8] FDA K200805 β€” Neocis Guidance System (NGS) with Patient Splints β†—U.S. Food and Drug Administration Β· regulatory record
[10] FDA K202264 β€” Neocis Guidance System (NGS) with Yomi Plan v2.0 β†—U.S. Food and Drug Administration Β· regulatory record
[12] FDA K210711 β€” Neocis Guidance System (NGS) with Yomi Plan v2.0.1 β†—U.S. Food and Drug Administration Β· regulatory record
[14] FDA K211466 β€” Yomi Robotic System with YomiPlan Go β†—U.S. Food and Drug Administration Β· regulatory record
[15] FDA K222049 β€” Yomi Robotic System β†—U.S. Food and Drug Administration Β· regulatory record
[16] FDA K222750 β€” Yomi Robotic System β†—U.S. Food and Drug Administration Β· regulatory record
[17] FDA K231018 β€” Yomi Robotic System β†—U.S. Food and Drug Administration Β· regulatory record
[18] FDA K251835 β€” Yomi Robotic System β†—U.S. Food and Drug Administration Β· regulatory record
[19] FDA K252376 β€” Yomi S Robotic System β†—U.S. Food and Drug Administration Β· regulatory record
[22] FDA PMA database β€” research search β†—FDA / openFDA Β· regulatory record
[23] FDA recall Z-0511-2020 β€” Neocis Inc. β†—U.S. Food and Drug Administration Β· regulatory record
[24] FDA recall Z-2637-2020 β€” Neocis Inc. β†—U.S. Food and Drug Administration Β· regulatory record
[25] FDA recall Z-2638-2020 β€” Neocis Inc. β†—U.S. Food and Drug Administration Β· regulatory record
[26] FDA recall Z-2639-2020 β€” Neocis Inc. β†—U.S. Food and Drug Administration Β· regulatory record
[27] FDA recall Z-0929-2021 β€” Neocis, Inc. β†—U.S. Food and Drug Administration Β· regulatory record
[29] FDA UDI database β€” research search β†—FDA / openFDA Β· regulatory record
[30] FDA 510(k) K252376 β†—U.S. Food and Drug Administration Β· regulatory database
[31] Yomi S launch announcement β†—Neocis Β· company website
[33] Company and Yomi platform β†—Neocis Β· company website
[35] Current leadership β†—Neocis Β· company website
Company research

Compare companies

Privacy choices

Your saved-company and comparison preferences are stored separately. Changing analytics preferences does not clear them.

About cookies and privacy